Amgen Inc (NASDAQ:AMGN)

175.89
Delayed Data
As of 4:15pm ET
 -2.50 / -1.40%
Today’s Change
166.30
Today|||52-Week Range
210.19
-9.65%
Year-to-Date

Today’s Trading

Previous close178.39
Today’s open177.83
Day’s range175.72 - 178.81
Volume2,556,793
Average volume (3 months)2,815,710
Market cap$108.8B
Data as of 4:15pm ET, 07/22/2019

Growth & Valuation

Earnings growth (last year)+368.59%
Earnings growth (this year)-2.90%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+4.32%
P/E ratio14.0
Price/Sales5.45
Price/Book8.99

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.13-0.20%
BIIBBiogen+1.21+0.52%
ILMNIllumina Inc+5.08+1.73%
EXASExact Sciences Corp+1.17+1.02%
Data as of 4:15pm ET, 07/22/2019

Financials

Next reporting dateJuly 30, 2019
EPS forecast (this quarter)$3.60
Annual revenue (last year)$23.8B
Annual profit (last year)$8.4B
Net profit margin35.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts